Skip to contentClarengateINTELLIGENCE
Companies/06029069

Absynth Biologics Limited

Company profile

DissolvedUnited Kingdom
Register Ask analyst

Financial position

Accounts to 2019-08-31 · GBP · unknown scope

Net assets
£814
Cash
£1,330
Turnover
—
Profit / loss
—
Current assets
£1,330
Creditors < 1 year
—
Equity
£814
Average employees
Not available

Balance-sheet trend

GBP · unknown

Two periods with a known, matching scope are needed for a trend.

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

4 periods
Reported figures2019-08-31GBP · unknown2018-02-28GBP · unknown2017-07-31GBP · unknown2016-07-31GBP · unknown
Balance sheet
Net assets£814−£756,946−£596,007−£493,618
Equity£814−£756,946−£596,007−£493,618
Assets
Fixed assets———£2,750
Intangible assets———£2,750
Property, plant & equipment——£84,304—
Current assets£1,330£4,084£136,670£98,005
Cash at bank£1,330£1,404£34,327£17,878
Debtors—£2,680£102,343£80,127
Liabilities
Creditors within one year——£432,086£228,263
Creditors after one year——£384,895£366,110
Net current assets£814−£396,946−£295,416−£130,258
Assets less current liabilities——−£211,112−£127,508
People
Average employees——55
Source evidenceView filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Register status requires review: Dissolved.

No charges available in our records.